Esophageal varices with bleeding
MONDO:002164536 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a dissolvable sponge replace medical glue for dangerous stomach vein bleeds?
Disease control Not yet recruitingThis trial tests whether an absorbable gelatin sponge works as well as cyanoacrylate glue for closing off enlarged stomach veins that can bleed. Both treatments are delivered via endoscopy with small coils. Participants are adults with a history of bleeding from these veins, and …
Phase: NA • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a common ulcer drug prevent deadly bleeding after variceal treatment?
Disease control Not yet recruitingThis trial tests whether applying sucralfate—a medication that forms a protective barrier over wounds—directly onto esophageal ulcers after variceal banding can speed healing and reduce rebleeding. The study includes adults with cirrhosis who have bleeding esophageal varices. Par…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New needle route may stop deadly bleeding in clogged portal veins
Disease control Not yet recruitingThis study tests a new procedure for people with a completely blocked main portal vein who have had at least two episodes of dangerous variceal bleeding. Doctors will use ultrasound to guide a needle into a vein in the gut, then try to reopen the blocked vein or create a new bypa…
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New blood thinner trial aims to prevent rebleeding in liver patients
Disease control Not yet recruitingThis study tests whether the blood thinner rivaroxaban can safely improve outcomes in people with liver cirrhosis who have both a blood clot in the portal vein and a high risk of variceal bleeding. About 175 participants will receive rivaroxaban or standard care starting 48 hours…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New stent technique could reduce deadly rebleeding in liver cirrhosis
Disease control Not yet recruitingThis study compares a new procedure using a special stent (underdilated VCX-TIPS) with standard treatment (endoscopic banding plus beta-blockers) to prevent variceal rebleeding in people with cirrhosis. The new approach uses a smaller balloon to expand the stent, aiming to lower …
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to stop deadly bleeding in liver patients
Disease control Not yet recruitingThis study looks at two treatments—endoscopy and a procedure called TIPS—to prevent repeat bleeding from enlarged veins in the stomach or esophagus caused by liver disease. Over 1,000 adults with this condition will be followed for a year to see which approach works better. The g…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New Fiber-Optic tech aims to make liver shunt surgery safer
Disease control Not yet recruitingThis study tests a fiber-optic navigation system that gives doctors a 3D view during a procedure called TIPS, which treats complications of liver cirrhosis like fluid buildup or bleeding. About 30 patients will be enrolled to see if the device reduces the number of needle sticks,…
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New stent aims to ease dangerous liver complications
Disease control Not yet recruitingThis study tracks 152 adults with cirrhosis who receive a special stent to treat complications like fluid buildup in the belly or bleeding from enlarged veins. The stent creates a new blood-flow path in the liver. Researchers will monitor how well it works and its safety over 2 y…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?
Disease control Not yet recruitingThis phase 3 trial tests whether adding albumin to standard treatment reduces re-bleeding and death in adults with cirrhosis who have acute variceal bleeding. Sixty participants will be randomly assigned to receive either albumin for three days plus standard care, or standard car…
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New Ultrasound-Guided procedure could reduce bleeding risk in cirrhosis patients
Disease control Not yet recruitingThis study tests a new procedure using an endoscopic ultrasound to guide the injection of tiny particles into the spleen, reducing blood flow and lowering the risk of dangerous bleeding in people with liver cirrhosis. The goal is to see if this method is safer and more effective …
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Hypnosis as a hospital treatment for gut disorders?
Symptom relief Not yet recruitingThis pilot study compares recorded gut-directed hypnosis to an educational recording for hospitalized patients with chronic gut problems, such as irritable bowel syndrome or inflammatory bowel disease. Participants listen to the recordings over the phone while in the hospital for…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ultrasound may replace scopes for bleeding risk in liver patients
Knowledge-focused Not yet recruitingThis study looks at whether a simple, non-invasive ultrasound can predict the risk of dangerous bleeding from enlarged veins in the esophagus (varices) in people with liver cirrhosis. Researchers will measure spleen size and a key blood vessel diameter on ultrasound and compare t…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC